Psammiad Therapeutics, Inc. — Form D

Psammiad Therapeutics, Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-22. The offering totals $3.0M, of which $2.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-02-22
• Form: D
• Accession: 0001911476-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $2.2M
• Remaining: $800K
• Minimum investment: $10K
• Investors: 5
• Date of first sale: 2022-01-31
• Revenue range: No Revenues
• SEC file number: 021-434323

Issuer

• Name: Psammiad Therapeutics, Inc.
• CIK: 0001911476
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 700 COLORADO BLVD, SUITE #118, DENVER, CO, 80206
• Phone: 720.820.0005

Officers, directors & promoters (4)

More

• CIK 1911476 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search